38 results
Thumbnail

D1.39 - Differential Diagnosis of Perioperative Anaphylaxis: The Hidden Role of Chlorhexidine

Thumbnail

D1.28 - Anaphylaxis after appendectomy: A case of allergy to sugammadex

Thumbnail

D1.29 - Class III Chitinases as Potential Allergens in Raspberry-Induced Anaphylaxis

Thumbnail

D1.30 - An exotic anaphylaxis in the mediterranean: due to a clinical case

Thumbnail

D1.31 - Quality Of Life In Alexithymic Patients With Anaphylaxis

Thumbnail

D1.32 - The effect of chelation on carmine allergy induced by epicutaneous sensitization to carmine in cosmetics

Thumbnail

D1.33 - Oat Allergy in a Young Adult: Allergenic Protein Profiling and Clinical Implications

Thumbnail

D1.34 - Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Thumbnail

D1.35 - Lipid transfer protein and Profilin-associated food-dependent exercise-induced anaphylaxis: A case series

Thumbnail

D1.36 - Prevalence of thaumatin and Alternaria co-sensitization

Thumbnail

D1.42 - Case Report of Allergy to Mint and Basil

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Thumbnail

D1.37 - Sometimes it is not what it seems

Thumbnail

D1.38 - Anaphylactic reaction to chia seeds: A case report

Thumbnail

D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Thumbnail

D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Thumbnail

D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117

Thumbnail

D2.354 - Questionnaire survey of new treatments for atopic dermatitis

Thumbnail

D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Thumbnail

D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria